Association between pan-immune inflammatory value and all-cause mortality in critically ill patients with ischemic stroke: a retrospective analysis of the MIMIC-IV database (2008–2022)
PIV is an independent predictor of short- and long-term mortality in critically ill ischemic stroke patients. These findings suggest PIV could serve as a practical and cost-effective biomarker for risk stratification and prognosis in clinical settings.
Authors
- Zhizhou Hu (ORCID: https://orcid.org/0009-0004-0264-2055)
- Xiao‐Hong Hu (ORCID: https://orcid.org/0000-0003-3104-0876)
- Qiaoying Huang (ORCID: https://orcid.org/0000-0001-6643-2509)
- Dan Jiang (ORCID: https://orcid.org/0000-0002-7053-0731)
- Anni Chen
- Yunnan Hu (ORCID: https://orcid.org/0000-0002-5790-9317)
- Jiahui Wang (ORCID: https://orcid.org/0009-0000-9529-0749)
- Jianhui Chen (ORCID: https://orcid.org/0000-0002-7757-6089)
- Liying Pan
Institutions
- Fujian Medical University (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2025-08-18
- DOI
- https://doi.org/10.3389/fneur.2025.1644817
- Citations
- 2
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 2.71